Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
27.47
+0.28 (1.03%)
Feb 3, 2026, 3:00 PM CST

SHA:600993 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,5413,0152,9882,4942,4312,073
Short-Term Investments
---138.81142.01215.37
Trading Asset Securities
1,108142.1463.29674.35106.0236.32
Cash & Short-Term Investments
2,6483,1573,0513,3072,6792,325
Cash Growth
-12.13%3.48%-7.72%23.45%15.22%42.20%
Accounts Receivable
649.32457.05334.67409.64242.87380.41
Other Receivables
56.8936.5142.5744.9824.9421
Receivables
706.21493.56377.24454.62267.81401.41
Inventory
328.78277.63273.48336.2313.92268.16
Other Current Assets
80.0946.5369.48128.18100.85117.05
Total Current Assets
3,7633,9753,7724,2263,3613,111
Property, Plant & Equipment
753.26770.89635.53515.34440.44344.06
Long-Term Investments
139.72148.95152.83151.47176.79226.08
Goodwill
25.2625.2625.2625.2625.2625.26
Other Intangible Assets
109.6293.0990.1137.2836.934.11
Long-Term Deferred Tax Assets
54.8950.5949.4658.3621.6321.03
Long-Term Deferred Charges
112.1113.482.366.5258.4461.38
Other Long-Term Assets
383.044.622.468.146.2743.24
Total Assets
5,3415,1824,8305,0884,1273,866
Accounts Payable
333.42337.66289.69284.74156.82152.31
Accrued Expenses
23.2669.53105.15118.5141.79190.95
Short-Term Debt
1431.845.888.188133
Current Portion of Long-Term Debt
13.81107.799.79---
Current Portion of Leases
-18.4323.1228.1321.14-
Current Income Taxes Payable
141.7767.236.2470.9860.4257.98
Current Unearned Revenue
79.5888.6591.86102.7588.18183.41
Other Current Liabilities
144.0483.379.43164.94109.0883.77
Total Current Liabilities
749.89804.36681.07858.14665.44801.43
Long-Term Debt
--100400--
Long-Term Leases
74.5876.293.5912273.21-
Long-Term Unearned Revenue
44.1654.5627.8926.9529.0317.03
Long-Term Deferred Tax Liabilities
22.0823.528.6135.372.512.93
Other Long-Term Liabilities
19.1122.0428.4629.5442.5398.5
Total Liabilities
909.82980.66959.621,472812.72919.89
Common Stock
431.05431.05431.05431.05431.05431.05
Additional Paid-In Capital
23.4623.5351.51100.74105.2118.11
Retained Earnings
3,8423,6083,2532,9602,6342,299
Comprehensive Income & Other
2.762.962.662.461.281.66
Total Common Equity
4,2994,0663,7383,4953,1712,849
Minority Interest
132.06135.32131.94121.5142.8297.16
Shareholders' Equity
4,4324,2013,8703,6163,3142,947
Total Liabilities & Equity
5,3415,1824,8305,0884,1273,866
Total Debt
102.39234.22272.29638.23182.35133
Net Cash (Debt)
2,5462,9232,7792,6692,4962,192
Net Cash Growth
-8.04%5.19%4.14%6.90%13.90%37.37%
Net Cash Per Share
5.936.816.466.195.805.07
Filing Date Shares Outstanding
431.05431.05431.05431.05431.05431.05
Total Common Shares Outstanding
431.05431.05431.05431.05431.05431.05
Working Capital
3,0143,1713,0913,3682,6962,310
Book Value Per Share
9.979.438.678.117.366.61
Tangible Book Value
4,1653,9483,6233,4323,1092,790
Tangible Book Value Per Share
9.669.168.407.967.216.47
Buildings
-289.57290.61293.35290.37277.13
Machinery
-447.54401.77402.1292.67277.89
Construction In Progress
-357.6205.7425.718.7534.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.